Source comparison
MK-677 vs Testosterone Replacement Therapy — Mechanism Comparison
Primary target pathway Ghrelin receptor → GH/IGF-1 axis Androgen receptor → anabolic signaling MK-677 targets anabolic pathways independent of testosterone, useful when hypogonadism isn't the primary issue Effect on endogenous hormone production No suppression
This comparison does not assign a generated winner or score.
- Primary target pathway
- Ghrelin receptor → GH/IGF-1 axis
- Androgen receptor → anabolic signaling
- MK-677 targets anabolic pathways independent of testosterone, useful when hypogonadism isn't the primary issue
- Effect on endogenous hormone production
- No suppression. Works through natural GH pulsatility
- Suppresses LH/FSH → testicular atrophy and spermatogenesis decline
- MK-677 preserves fertility and natural testosterone production; TRT requires post-cycle recovery or HCG co-administration
- Impact on lean body mass
- Increases 1.0–1.5kg over 12–24 weeks via mTOR activation and protein synthesis
- Increases 2.0–4.0kg depending on dose and training stimulus
- TRT produces greater absolute muscle gain; MK-677 produces lean mass increases without water retention
- Effect on bone mineral density
- Increases BMD 1.8–2.3% at hip and femoral neck over 24 months
- Increases BMD 2–5% over 12–24 months, dose-dependent
- Both improve bone health, but MK-677 acts through osteoblast stimulation rather than androgen-mediated pathways
- Metabolic side effects
- Increases fasting glucose 5–10mg/dL; modest insulin resistance at chronic dosing
- Increases hematocrit (red blood cell mass), potential cardiovascular strain
- MK-677 requires glucose monitoring in prediabetic patients; TRT requires hematocrit monitoring and potential therapeutic phlebotomy
- Administration route
- Oral, once daily
- Intramuscular injection (weekly to biweekly) or transdermal gel (daily)
- MK-677 offers convenience; TRT requires injection compliance or consistent topical application
- Regulatory status
- Research compound. Not FDA-approved for clinical use
- FDA-approved for hypogonadism under medical supervision
- TRT is a controlled prescription therapy; MK-677 is available through research peptide suppliers like Real Peptides